semaglutide concerns GLP-1 weight-loss drugs may also curb alcohol cravings Semaglutide vs Traditional Weight Loss:

One pilot study investigating a combination of glycine and N-acetylcysteine was shown to help older adults rather than younger ones, helping to reduce inflammation, glutathione deficiency, endothelial dysfunction, and 'multiple aging hallmarks'

Both formulations were mainly prescribed in patient at high (39.1% in oral and 31.6% in subcutaneous semaglutide group, respectively) or very high (45.2% in oral and 46.3% in subcutaneous semaglutide group, respectively) cardiovascular risk, without significant differences between the two groups (Supplementary Fig.S1v)

These GLP-1 drugs are ubiquitous in life - helping people manage diabetes and, hopefully, reducing their risk of cardiovascular disease, and even one day treating drug and alcohol addiction

10.1021/ar960017f 4 ArodaV